HE4 (Human Epididymis Protein 4)
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- diagnostic reagent, cancer diagnosis, tumor marker
- Category
- Medical Devices
Tellgen corporation
- Verified Certificate
-
9
Product name | HE4 (Human Epididymis Protein 4) | Certification | - |
---|---|---|---|
Category | Medical Devices | Ingredients | - |
Keyword | diagnostic reagent , cancer diagnosis , tumor marker | Unit Size | - |
Brand name | - | Unit Weigh | - |
origin | China | Stock | - |
Supply type | - | HS code | - |
Product Information
HE4 (Human Epididymis Protein 4)
Compatible instrument: Luminex 200,TESMI F4000 .
Reference Value: Females: < or =140 pmol/L
Tellgen also provide following Tumor markers and Tumor Marker control :
CA125
CA153
CA24-2
CYFRA21-1
AFP
CEA
CEA
total PSA
free PSA
free-beta-hCG
CA19-9
NSE
SCCA
CA72-4
CA50
HE4
ProGRP
PGI/PGII
Control 1
Control 2
Control 3
Increase in human epididymis protein 4 (HE4) suggests recurrence or disease progression, while a decrease suggests therapeutic response. A change in serum HE4 concentration of > or =20% is considered significant.
Human epididymis protein 4 (HE4) belongs to the family of whey acidic four-disulfide core proteins. Currently, the biologic function of HE4 is unknown.
HE4 has been shown to be overexpressed in 93% of serous, 100% of endometrioid, and 50% of clear cell ovarian carcinomas. In a study of 233 patients with a pelvic mass, including 67 with epithelial ovarian cancer, HE4 had a higher sensitivity for ovarian cancer detection than cancer antigen 125 (CA 125), 72.9% versus 43.3%, respectively, at a specificity of 95%. Researchers also found HE4 to be elevated in more than half of the ovarian cancer patients who did not have elevated CA 125 levels; therefore, the combination of markers provided slightly improved cancer diagnostic sensitivity for the detection of ovarian cancer.
The main established application of HE4 is in post-therapy monitoring of ovarian cancer patients, who had elevated pretreatment levels. In this setting, it complements CA 125 measurement and facilitates follow-up of patients with little or no CA 125 pretreatment elevations.
Certain histological types of ovarian cancer (mucinous or germ cell tumors) rarely express HE4, therefore the use of HE4 is not recommended for monitoring of patients with these types of ovarian cancer.
B2B Trade
Price (FOB) | Negotiable | transportation | - |
---|---|---|---|
MOQ | Negotiable | Leadtime | Negotiable |
Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Yao Jiaoer
- Address
- Building 1, No.115, Lane 572, Bibo road, Free trade area
- Product Category
- Other Monitoring & Diagnostic Equipment
- Year Established
- 2003
- No. of Total Employees
- 101-500
- Company introduction
-
Shanghai Tellgen Corporation. was founded in 2003 and dedicated exclusively to the development, production and distribution of high-quality automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. With the tremendous development, Tellgen became the the market leader in moleucular diagnosis area, and had consistently delivered series diagnostic products for healthcare
- Main Product
Related Products
Hairview
PRF BOX Implant
Implant system (SLA surface)
DISSECTING MEDICAL STUDENT KIT ANATOMY BIOLOGY STAINLESS
Covid 19 Detection